These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28679958)

  • 21. Newly Emergent Highly Pathogenic H5N9 Subtype Avian Influenza A Virus.
    Yu Y; Wang X; Jin T; Wang H; Si W; Yang H; Wu J; Yan Y; Liu G; Sang X; Wu X; Gao Y; Xia X; Yu X; Pan J; Gao GF; Zhou J
    J Virol; 2015 Sep; 89(17):8806-15. PubMed ID: 26085150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.
    Cox F; Kwaks T; Brandenburg B; Koldijk MH; Klaren V; Smal B; Korse HJ; Geelen E; Tettero L; Zuijdgeest D; Stoop EJ; Saeland E; Vogels R; Friesen RH; Koudstaal W; Goudsmit J
    Front Immunol; 2016; 7():399. PubMed ID: 27746785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
    Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
    J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
    Park S; Lee I; Kim JI; Bae JY; Yoo K; Kim J; Nam M; Park M; Yun SH; Cho WI; Kim YS; Ko YY; Park MS
    Biochem Biophys Res Commun; 2016 Oct; 479(2):192-197. PubMed ID: 27613087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.
    Jegaskanda S; Reading PC; Kent SJ
    J Immunol; 2014 Jul; 193(2):469-75. PubMed ID: 24994909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    Liu L; Nachbagauer R; Zhu L; Huang Y; Xie X; Jin S; Zhang A; Wan Y; Hirsh A; Tian D; Shi X; Dong Z; Yuan S; Hu Y; Krammer F; Zhang X; Xu J
    J Infect Dis; 2017 Feb; 215(4):518-528. PubMed ID: 28380622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
    Wang Y; Zhang Y; Wu J; Lin Y; Wu Z; Wei Y; Wei X; Qin J; Xue C; Liu GD; Cao Y
    Virus Res; 2017 Oct; 242():16-23. PubMed ID: 28912070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
    Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
    Liu WC; Lin YL; Spearman M; Cheng PY; Butler M; Wu SC
    J Virol; 2016 Jul; 90(13):6085-6096. PubMed ID: 27099319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.
    Wines BD; Vanderven HA; Esparon SE; Kristensen AB; Kent SJ; Hogarth PM
    J Immunol; 2016 Aug; 197(4):1507-16. PubMed ID: 27385782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
    Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
    Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
    Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human infection with a novel avian-origin influenza A (H7N9) virus.
    Gao R; Cao B; Hu Y; Feng Z; Wang D; Hu W; Chen J; Jie Z; Qiu H; Xu K; Xu X; Lu H; Zhu W; Gao Z; Xiang N; Shen Y; He Z; Gu Y; Zhang Z; Yang Y; Zhao X; Zhou L; Li X; Zou S; Zhang Y; Li X; Yang L; Guo J; Dong J; Li Q; Dong L; Zhu Y; Bai T; Wang S; Hao P; Yang W; Zhang Y; Han J; Yu H; Li D; Gao GF; Wu G; Wang Y; Yuan Z; Shu Y
    N Engl J Med; 2013 May; 368(20):1888-97. PubMed ID: 23577628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first lack of evidence of H7N9 avian influenza virus infections among pigs in Eastern China.
    Zhao FR; Zhou DH; Lin T; Shao JJ; Wei P; Zhang YG; Chang HY
    Microb Pathog; 2015 Mar; 80():63-6. PubMed ID: 25680835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
    Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.